Barrett Esophagus Market 2023-2031: Growing Number of GERD Cases to Drive the Market: Effective and Advance Industry Research by Reports and Insights
The key objective of the newly published report by Reports & Insights termed as "Barrett Esophagus Market: Opportunity Analysis and Future Assessment 2023-2031", is to offer its clients with an absolute all-embracing, superior quality primary data about the market potential and profound knowledge of the trends prevailing in the market. Reports & Insights provides the in-depth knowledge of the market developed by the acknowledged market expertise using verified research methodologies and proven analytical approaches. For the interest and intrigue of the readers, the report comes across at the outcome with a strong focus on the thorough outlining of the key players of the global barrett esophagus market.
The global barrett esophagus market in 2020 is accounted for more than US$ xx Mn and expected to reach a value of US$ xx Mn by 2028 with a significant CAGR of 4.1%.
Request To Download Sample of Barrett Esophagus Market Report: https://reportsandinsights.com/sample-request/1223
Reports and Insights Overview
The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
Barrett Esophagus Introduction
Barrett’s esophagus is a disorder, also known as Barrett's syndrome or columnar epithelium lined lower esophagus, in which there is an unusual variation in the interior lining of oesophagus (lower portion) . The stomach cells (goblet cells) take the place of the cells of the esophagus (stratified squamous) . This replacement of cells occurs due to the activity of stomach acids (chronic acids) . The stomach acids are likely to leak into the food pipe or esophagus, if the enclosure of muscles at the lower part of oesophagus does not close firmly, which may cause harm to the esophageal cells over time and may result in Barrett’s esophagus.
The common signs and symptoms of Barrett Esophagus are similar to that of Gastroesophageal reflux disease (GERD) that is dysphagia, heartburn, sensation of a lump in the throat, acid reflux, dry cough, and chest pain. Generally this disease is diagnosed with the help of biopsy and endoscopy. Once the disease is diagnosed, patients are prescribed for the intake of acid-suppressing medications, also known as proton pump inhibitors.
There are different acid-suppressing medications patients could intake including pantoprazole, omeprazole, lansoprazole, esomeprazole, and rabeprazole. The medical care of Barrett Esophagus may also involve surgeries that include ablative therapies (radiofrequency ablation, photodynamic therapy), mucosal resection and esophagectomy. The patients are also usually advised to make dietary changes to reduce the risk of Barrett’s esophagus. This can be achieved by escalating the intake of vitamins, vegetables, and fruits.
Some of the key questions answered in this report:
Barrett Esophagus Market Dynamics
The growing prevalence of Barrett Esophagus or Barrett’s Syndrome among the masses across the world is one of the major factors that is boosting the growth of the global barrett esophagus market. As per the estimates, approximately 1.6% to 6.8% of the total global population suffers from the disease every year till date and this share is projected to escalate over the forecast period. In addition to that, there are also a rising number of patients suffering from GERD which further elevates the risk of Barrett’s esophagus, thereby propelling the growth of the global Barrett's esophagus market in the forthcoming years.
Furthermore, the rising count of surgical interventions and procedures in different disease conditions is also playing a positive role in providing significant growth opportunities for the global Barrett Esophagus market in the coming years.
Rising incidence related to esophageal diseases is major factor driving growth of the global barrett esophagus market across the globe. Also increasing number of patients suffering from gastro esophagus reflux disease (GERD) that increases the risk of barrett’s esophagus will propel growth of the global market over the forecast period. Increasing changes in the lifestyle are leading to increasing consumption of alcohol causing GERD among people and obesity are expected to drive the growth barrett’s esophagus market globally. According to data published by World Health Organization (WHO), in 2018, alcohol consumption leads to 3 Mn deaths each year globally as well as to the disabilities and poor health of millions of people. In addition, 9.6 Mn people worldwide are accounted to die from cancer in 2018. However, the asymptomatic condition of barrett’s esophagus, patent expiry of drugs employed for the treatment of GERD, and the availability of over-the counter drugs are some of the factor which are expected to act as a barrier in the growth of the global barrett esophagus market in the near future. Nevertheless, growing number of surgical procedures and surgical interventions in various disease conditions are expected to create immense growth opportunities for the global postoperative pain management market over the forecast period.
Barrett Esophagus Market Segmentation
Global barrett esophagus market is segmented on the basis of treatment, distribution channel, and by region.
ï‚§ Proton Pump Inhibitors
ï‚§ H2 Blockers
ï‚§ Promotility Agents
ïƒ˜ Surgical Treatment
ï‚§ Radiofrequency Ablation
ï‚§ Photodynamic Therapy
ï‚§ Endoscopic Spray Cryotherapy
ï‚§ Endoscopic Mucosal Resection
Alphabeticals: - Barrett Esophagus Market
By Distribution Channel:
ïƒ˜ Hospital Pharmacies
ïƒ˜ Retail Pharmacies
ïƒ˜ Over The Counter
ïƒ˜ North America
ïƒ˜ Asia Pacific
ïƒ˜ Latin America
ïƒ˜ Middle East
Barrett Esophagus Market Drugs Overview
Endoscopy and biopsy are main processes which helps to diagnosed Barrett’s esophagus syndrome. After the diagnosis of disease in patient body, patients are prescribed for proton pump inhibitors in which uptake of acid-suppressing medications is done. Omeprazole, pantoprazole, lansoprazole, esomeprazole, and rabeprazole are some of the various drugs which includes in proton pump inhibitors. Healthcare experts also recommend surgery for the treatment of barrett’s esophagus complication which includes ablative therapies i.e. radiofrequency ablation and photodynamic therapy, and esophagectomy and mucosal resection. Risk of barrett’s esophagus can be avoided with the help of dietary changes with the help of increasing intake of more vegetables, vitamins and fruits in person’s regular meals for the day.
Barrett's esophagus can be classified into three categories:
Source: Drugbank, 2018
Barrett Esophagus Market Competitive Landscape
Some of the key participating players in global barrett esophagus market are Addex Therapeutics, AstraZeneca, Plc., Rottapharm (Meda AB), Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Pfizer, Inc., Torax Medical, Mederi Therapeutics, Aros Pharma, Torax Medical, Inc., and C. R. Bard.
On the basis of region, the barrett esophagus market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
To view Top Players, Segmentation and other Statistics of Barrett Esophagus Industry, Get Sample Report @: https://reportsandinsights.com/free-customization/1223
About Reports and Insights:
Reports and Insights is one of the leading market research companies which offers syndicate and consulting research around the globe. At Reports and Insights, we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
1820 Avenue M, Brooklyn
NY 11230, United States
+1- (718) 312-8686
Find Us on Linkedin: www.linkedin.com/company/report-and-insights/
Sign up and publish your articles.